Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02737553
Other study ID # AAkdemir1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2016
Est. completion date February 2020

Study information

Verified date February 2021
Source Ege University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Laparoscopic tissue removal is one of the most challenging parts for the laparoscopic surgery. For this reason, electromechanical morcellation has long been used to facilitate the tissue removal in gynecology. However, electromechanical morcellation has long been performed inside the abdomen without any containment. Therefore, this practice has recently undergone increased scrutiny because of important concerns related to tissue dissemination during intracorporeal power morcellation. Thus, the US Food and Drug Administration released a safety communication discouraging power morcellation in laparoscopic hysterectomy and myomectomy procedures in April 2014. As a result of this serious concern, the enclosed laparoscopic power morcellation has been come into prominence in gynecological surgery. Besides the removal of the tissues through vagina with posterior colpotomy is considered an another solution for this critical problem. In the literature the comparison for the two techniques for tissue removal is considerably scarce. Therefore researchers are aiming to prepare a trial to compare the laparoscopic enclosed electromechanical morcellation and tissue removal thorough vagina with posterior colpotomy according to surgical time, postoperative pain and postoperative sexual function.


Description:

In this study researchers aiming to compare the compare the laparoscopic enclosed electromechanical morcellation and tissue removal thorough vagina with posterior colpotomy according to surgical time, postoperative pain and postoperative sexual function. Patients with an indication of myomectomy, between 18 to 40 years old, without prior abdominal surgery and without suspicious of malignancy will include into the study. Anticipated number of the patients will be 60. Participants will be randomized into two groups; group 1 enclosed electromechanical morcellation will be performed to remove the myoma out of the abdominal cavity; group 2 myoma will be removed through vagina with posterior colpotomy. In group 1, after extirpation of the myoma from the uterus and repair of the uterine defect, the myoma will be removed from the abdomen with an enclosed laparoscopic electromechanical morcellation with using surgical glove. In group 2, after extirpation of myoma from uterus and repair of the uterine defect, myoma will be removed through the vagina with posterior colpotomy. In this group myoma will also be removed in a enclosed fashion with using endo bag. Tissue removal time (for group 1 removal time is decided time between the insertion and removal of the morcellation, for group two removal time is decided time between start of the posterior colpotomy and end of the closure of the posterior colpotomy), postoperative time and sexual function of the patient and any of the complications will be compared. Visual pain score and female sexual function index questionnaire will be used to assess the postoperative pain and sexual function, respectively.


Recruitment information / eligibility

Status Completed
Enrollment 118
Est. completion date February 2020
Est. primary completion date February 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Myoma Uteri - No prior abdominal surgery Exclusion Criteria: - Suspicious for malignancy - Prior abdominal surgery - no vaginal intercourse

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Enclosed morcellation
After extirpation of the myoma from the uterus and repair of the uterine defect, the myoma will be removed from the abdomen with an enclosed laparoscopic electromechanical morcellation as described in the literature by Akdemir et al with using surgical glove (Akdemir A et. al, Innovative technique for enclosed morcellation using a surgical glove. Obstet Gynecol. 2015 May;125(5):1145-9. doi: 10.1097/AOG.0000000000000823.).
vaginal morcellation
After extirpation of myoma from uterus and repair of the uterine defect, myoma will be removed through the vagina with posterior colpotomy. In this group myoma will also be removed in a enclosed fashion with using endo bag.

Locations

Country Name City State
Turkey Department of Obstetrics and Gynecology, Ege University School of Medicine Izmir Bornova

Sponsors (1)

Lead Sponsor Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Other Postoperative Pain Postoperative pain was compared between two groups using visual analog score in 0 to 10 scale.
Participants were assessed in terms of pain with the Visual Pain Scale (VAS). The participants were asked to rate current pain on a 10-cm visual analog scale (VAS), with 0 being no pain and 10 the worst pain imaginable 48 hours after operation.
2 day
Other Sexual Functional Assessment Sexual function will be assessed with using "Female Sexual Function Index questionnaire" and it will be compared between two groups.
Participants were requested to fill FSFI (Female Sexual Function Index) forms to evaluate their sexual lives. The FSFI consists of 19 questions and is a validated questionnaire for the assessment of sexual function. The questions are grouped into the subdomains of libido, arousal, lubrication, orgasm, satisfaction, and pain. The total score is determined by summing up the subdomains scores. Higher scores reflect better sexual function; maximum score is 36 and minimum score is 0. For each subdomain, higher scores reflect better sexual function; maximum score is 6 and minimum score is 0 including pain, in which 0 reflects lots of pain and 6 reflects the absence of pain.
3 months
Primary Operation Time Total operation time will be compared between two groups in seconds. 1 day
Secondary Morcellation Time After extirpation of the myoma in group 1 the fibroid was placed into the glove within the abdomen. The morcellation was accomplished within the completely enclosed glove. In Group 2, after extirpation of the myoma, it was removed through the vagina through posterior colpotomy. An endoscopic specimen bag was placed into the abdomen following the vaginal posterior colpotomy. Then, the fibroid was placed into the endoscopic bag within the abdomen. The specimen was removed with coring technique via scalpel. Posterior colpotomy incision was then sutured vaginally.
Morcellation time is decided time between the insertion and removal of the surgical glove in group 1 and time between start of the posterior colpotomy and end of the closure of the posterior colpotomy in group 2. Tissue morcellation time compared between two groups in seconds.
1 day
See also
  Status Clinical Trial Phase
Completed NCT00528177 - Morphine vs. Oxycodone for Postoperative Pain Management Phase 4
Completed NCT05925153 - Vision Screening Study for College Students at Nankai University
Completed NCT00891657 - Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy N/A
Completed NCT03972917 - Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy
Completed NCT02747550 - Temporary Simultaneous Two-arterial Occlusions During Laparoscopic Myomectomy N/A
Completed NCT00898170 - Effect of Myoma Removal on Blood Pressure and Erythropoetin Level N/A
Withdrawn NCT02377492 - Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy N/A
Recruiting NCT05806307 - Methods Decreasing Bleeding in Open Myomectomy Phase 4
Recruiting NCT00351494 - Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization N/A
Completed NCT00562471 - Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation Phase 1/Phase 2
Recruiting NCT01564602 - To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy N/A
Completed NCT01032213 - Effect of Magnesium Sulphate on Coagulation N/A
Completed NCT03427671 - OCL 500 Treatment of Women With Symptomatic Uterine Fibroids N/A
Not yet recruiting NCT04694677 - Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy. N/A
Completed NCT04983719 - Transcervical Myoma Biopsy Video
Recruiting NCT05170230 - The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations N/A
Recruiting NCT05683041 - Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy N/A
Recruiting NCT05242783 - The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets: N/A
Recruiting NCT05266534 - The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets N/A
Completed NCT02853695 - Implementation of Hysteroscopy in Flanders and the Netherlands